CDX2 as a Prognostic Biomarker in Colon Cancer

N Engl J Med. 2016 Jun 2;374(22):2183-4. doi: 10.1056/NEJMc1602584.
No abstract available

Publication types

  • Letter
  • Kommentar

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / metabolism*
  • Colonic Neoplasms / genetics*
  • Female
  • Gene Expression*
  • Homeodomain Proteins / metabolism*
  • Humans
  • Male

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Homeodomain Proteins